Published in Hepatitis Weekly, March 17th, 2008
"In this study, the in vitro anti-HSV-1 and HSV-2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.